AUTHOR=Chuai Fang , Dong Tong , Liu Yuan , Jiang Wen , Zhang Lanmei , Chen Lei , Chuai Yunhai , Zhou Yuhang TITLE=The effect of intrapartum prolonged oxygen exposure on fetal metabolic status: secondary analysis from a randomized controlled trial JOURNAL=Frontiers in Endocrinology VOLUME=14 YEAR=2023 URL=https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2023.1204956 DOI=10.3389/fendo.2023.1204956 ISSN=1664-2392 ABSTRACT=Objective

The aim of the study is to assess the effect of maternal prolonged oxygen exposure during labor on fetal acid–base status, fetal heart rate tracings, and umbilical cord arterial metabolites.

Design

The study was conducted as a secondary analysis.

Setting(s)

The study was set in three tertiary teaching hospitals in Beijing, China.

Participants

Approximately 140 women in the latent phase of labor with no complications participated in the study.

Intervention

Participants were randomly allocated in a 1:1 ratio to receive either 10 L of oxygen per minute in a tight-fitting simple facemask until delivery or room air only.

Main outcome measures

The primary outcome was the umbilical cord arterial lactate.

Results

Baseline demographics and labor outcomes were similar between the oxygen and room air groups; the time from randomization to delivery was 322 ± 147 min. There were no differences between the two groups in the umbilical cord arterial lactate (mean difference 0.3 mmol/L, 95% confidence interval −0.2 to 0.9), the number of participants with high-risk category II fetal heart rate tracings (relative risk 0.94, 95% confidence interval 0.68 to 1.32), or the duration of those high-risk tracings (mean difference 3.6 min, 95% confidence interval −9.3 to 16.4). Prolonged oxygen exposure significantly altered 91 umbilical cord arterial metabolites, and these alterations did not appear to be related to oxidative stress.

Conclusion

Maternal prolonged oxygen exposure during labor did not affect either the umbilical cord arterial lactate or high-risk category II fetal heart rate tracings but might result in alterations to the umbilical cord arterial metabolic profile.

Clinical trial registration

www.clinicaltrials.gov, identifier NCT03764696.